The advent of new therapies brings new manufacturing challenges for biopharma. As an example, subcutaneous injections of high-concentration monoclonal antibodies (mAbs) are already transforming the patient experience. But with up to 10 times greater concentrations, these viscous fluids are pushing the limits of what traditional filtration can handle efficiently. This leads to slow processing and the loss of valuable product. The new range of Supor™ Prime sterilizing-grade filters from Cytiva changes that.
In this GEN webinar—the global launch event for Supor Prime filters—you will discover one of the biggest breakthroughs in filter performance for a decade. Our expert panel will discuss how the Supor Prime filter range can help you do more and do it faster, thereby accelerating and advancing therapeutics from discovery to delivery. Among the topics covered in this roundtable will be:
- The changing biopharma landscape and the filtration challenges it faces
- How the Supor Prime filter range can double throughput and increase flow rate
- A behind-the-scenes look at the development of the range
- A close-up of the product range showcasing its innovative, user-friendly design.
